vimarsana.com
Home
Live Updates
Rain Therapeutics Inc. (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript : comparemela.com
Rain Therapeutics Inc. (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Related Keywords
United States ,
Joe Catanzaro ,
Tony Butler ,
Sam Slutsky ,
Mitchell Kapoor ,
Yigal Nochomovitz ,
Nelson Cabatuan ,
Richard Bryce ,
Graig Suvannavejh ,
Robert Doebele ,
Michael Schmidt ,
Faisal Khurshid ,
Bob Doebele ,
Piper Sandler ,
Jeff Jones ,
Avantika Joshi ,
Avanish Vellanki ,
Soumit Roy ,
Memorial Sloan Kettering Cancer Center ,
Rain Oncology Inc ,
Nasdaq ,
Exchange Commission ,
Rain Therapeutics Inc ,
Citigroup ,
Brain Therapeutics ,
Call Transcript May ,
Rain Oncology ,
First Quarter ,
Chief Executive Officer ,
Chief Scientific Officer ,
Chief Medical Officer ,
Private Securities Litigation Reform Act ,
Clinical Oncology ,
comparemela.com © 2020. All Rights Reserved.